Drugs.com - Pharma Industry News

FDA Approves Dupixent for Bullous Pemphigoid

TUESDAY, June 24, 2025 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.The approval is based on results from the pivotal ADEPT phase 2/3 study. Patients with...

Jun 24, 2025 - 23:05
 0
FDA Approves Dupixent for Bullous Pemphigoid
TUESDAY, June 24, 2025 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.The approval is based on results from the pivotal ADEPT phase 2/3 study. Patients with...
Read More

Tags:

Previous Article

Mild Obstructive Sleep Apnea More Common in Female Athletes Than Expected

Next Article

STAT+: Top FDA drug regulator tells staff much is still in flux, as she prepares...

Related Posts

Decline in Youth Physical Fitness Seen in Association With Pandemic

Decline in Youth Physical Fitness Seen in Association W...

Jun 13, 2025  0

High-Volume Exercise Tied to Increased Coronary Artery Calcification Score

High-Volume Exercise Tied to Increased Coronary Artery ...

May 28, 2025  0

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

Mitochondrial Genetics Key to Metastatic Melanoma Immun...

Jun 12, 2025  0